Abstract
Introduction
Medication errors are a preventable cause of patient injury. In May 2003, as a result of a joint initiative by the Royal College of Anaesthetists, the Association of Anaesthetists of Great Britain and Ireland, the Intercollegiate Faculty of Accident and Emergency Medicine and the Intensive Care Society, a new colour code chart for syringe labelling was introduced. The introduction of the new system has not been uniform in the Irish Republic with no national guidelines or time scale in place.
Methods
A questionnaire was administered to doctors working in Anaesthesia in two Dublin teaching hospitals.
Results
As much as 23% had administered an incorrect medication and 53% admitted to a near miss as a result of the introduction of the new label.
Discussion
Future action should focus on practical, common sense interventions including techniques such as those that reduce reliance on memory, standardization, the use of protocols and checklists, and the elimination of look-alike products.
Similar content being viewed by others
References
Leape LL (1995) Preventing adverse drug events. Am J Health Syst Pharm 52:379–382
Weingart SN, Wilson RM, Gibberd RW, Harrison B (2000) Epidemiology of medical error. BMJ 320(7237):774–777. doi:10.1136/bmj.320.7237.774
Brennan TA (2000) The Institute of Medicine report on medical errors: could it do harm? N Engl J Med 342(15):1123–1125. doi:10.1056/NEJM200004133421510
Zellmer WA (1993) Medication error versus medication misadventure: what’s in a name? Am J Hosp Pharm 50(2):315–318
Allan EL, Barker KN (1990) Fundamentals of medication error research. Am J Hosp Pharm 47(3):555–571
Bates DW, Spell N et al (1997) The costs of adverse drug events in hospitalized patients: Adverse Drug Events Prevention Study Group. JAMA. 277(4):307–311
Lane C, Goldman L (1993) Guidelines on preventing medication errors in hospitals. Am J Hosp Pharm 50(2):305–314
Pepper GA (1995) Errors in drug administration by nurses. Am J Health Syst Pharm 52(4):390–395
Birks RJ, Simpson PJ (2003) Syringe labelling: an international standard. Anaesthesia 58(6):518–519. doi:10.1046/j.1365-2044.2003.03259.x
Chopra V, Bovill JG et al (1992) Reported significant observations during anaesthesia: a prospective analysis over an 18-month period. Br J Anaesth 68:13–17. doi:10.1093/bja/68.1.13
Currie M, Mackay P, Morgan C et al (1993) The “wrong drug” problem in anaesthesia: an analysis of 2,000 incident reports. Anaesth Intensive Care 21:596–601
Windsor JA, Pong J (1998) Laparoscopic biliary injury: more than a learning curve problem. Aust N Z J Surg 68:186–189. doi:10.1111/j.1445-2197.1998.tb04742.x
Johnson JA, Bootman JL (1997) Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm 54:554–558
Brennan TA, Sox CM et al (1996) Relation between negligent adverse events and the outcomes of medical malpractice litigation. N Engl J Med 335:1963–1967. doi:10.1056/NEJM199612263352606
Cooper JB, Newbower RS et al (1984) An analysis of major errors and equipment failures in anesthesia management: considerations for prevention and detection. Anesthesiology 60:34–42. doi:10.1097/00000542-198401000-00008
Author information
Authors and Affiliations
Corresponding author
Appendices
Appendix 1
Appendix 2
Appendix 3
Rights and permissions
About this article
Cite this article
Shannon, J., O’Riain, S. Introduction of “international syringe labelling” in the Republic of Ireland. Ir J Med Sci 178, 291–296 (2009). https://doi.org/10.1007/s11845-009-0342-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-009-0342-4